LBA86 Randomised phase III trial of androgen deprivation therapy (ADT) with radiation therapy with or without enzalutamide for high risk, clinically localised prostate cancer: ENZARAD (ANZUP 1303)
P.L. Nguyen, C. Sweeney, M.R. Stockler, Heidi Thomas, Blossom Mak, Aiqin Zhang, Tee Lim, Caroline José, J. Martin, Nitya Patanjali, David Pryor, Phuoc T. Tran, Stephen Mangar, Alina Mihai, M Beresford, F. Sedlmayer, Paul Kelly, Simon Hughes, I.D. Davis, Sophie Williams
Topics & Concepts
MedicineEnzalutamideAndrogen deprivation therapyInternal medicineOncologyProstate cancerRadiation therapyPhases of clinical researchClinical trialUrologyProstateAndrogenAntiandrogenProstate-specific antigenRandomized controlled trialProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentUrinary Bladder and Prostate Research